Thermo Fisher Scientific Reports First Quarter 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/1/2026
- Wall Street ends choppy session lower as tech shares drop
- Meta Platforms stock surges 8% on cloud business plans
- Humanoid robot component stocks surge on supply-chain optimism
- Oil prices fall 1% to 4-month lows as progress in US-Iran talks cools supply concerns
- Trump discloses over $1.4 billion in crypto income in 2025 filing
- Whirlpool to close Mexico plant, expects $165M restructuring cost
- S&P 500, Nasdaq register best quarter since 2020 despite Iran war
- Cantor Fitzgerald Starts Forward Industries (FWDI) at Overweight
- DISH DBS files prepackaged chapter 11 to repay debt, wind down wireless
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
Thermo Fisher Scientific (TMO) Tops Q1 EPS by 8c, Revenues Beat; Raises FY19 EPS/Revenue Guidance Above Consensus
April 24, 2019 6:05 AM EDTThermo Fisher Scientific (NYSE: TMO) reported Q1 EPS of $2.81, $0.08 better than the analyst estimate of $2.73. Revenue for the quarter came in at $6.12 billion versus the consensus estimate of $6.02 billion.
First quarter revenue increased to $6.12 billion.First quarter GAAP diluted earnings per share (EPS) increased 41% to $2.02.First quarter adjusted EPS increased 12% to $2.81.Launched a range of new products, including two Thermo Scientific instruments for materials analysis the Nicolet Summit FTIR spectrometer and the Helios 5 DualBeam scanning electron microscope and in specialty diagnostics, received FDA clearance for a new ImmunoCAP... More